Literature DB >> 18162128

Expression of genes for bone morphogenetic proteins BMP-2, BMP-4 and BMP-6 in various parts of the human skeleton.

Iwona Kochanowska1, Slawomir Chaberek, Andrzej Wojtowicz, Bartosz Marczyński, Krzysztof Włodarski, Maria Dytko, Kazimierz Ostrowski.   

Abstract

BACKGROUND: Differences in duration of bone healing in various parts of the human skeleton are common experience for orthopaedic surgeons. The reason for these differences is not obvious and not clear.
METHODS: In this paper we decided to measure by the use of real-time RT-PCR technique the level of expression of genes for some isoforms of bone morphogenetic proteins (BMPs), whose role is proven in bone formation, bone induction and bone turnover. Seven bone samples recovered from various parts of skeletons from six cadavers of young healthy men who died in traffic accidents were collected. Activity of genes for BMP-2, -4 and -6 was measured by the use of fluorescent SYBR Green I.
RESULTS: It was found that expression of m-RNA for BMP-2 and BMP-4 is higher in trabecular bone in epiphyses of long bones, cranial flat bones and corpus mandibulae then in the compact bone of diaphyses of long bones. In all samples examined the expression of m-RNA for BMP-4 was higher than for BMP-2.
CONCLUSION: It was shown that m-RNA for BMP-6 is not expressed in the collected samples at all. It is postulated that differences in the level of activation of genes for BMPs is one of the important factors which determine the differences in duration of bone healing of various parts of the human skeleton.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162128      PMCID: PMC2244626          DOI: 10.1186/1471-2474-8-128

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


Background

Bone mass is a changeable parameter. Its peak is reached in the age of 30–35 years. Bone turnover is under the control of two cell populations – osteoblasts and osteoclasts. These cells are influenced by many factors which control the balance of bone formation and bone resorption. The same cell populations and factors are active in bone healing. Bone morphogenetic proteins (BMPs) are involved in many processes which take place in bone formation, bone induction, and bone regeneration as e.g. callus formation in the course of bone healing. The full picture of bone turnover is not completed as yet, although many factors and interactions are well described. The complexity of bone turnover involves the long list of about 200 factors influencing each other in various physiological and/or pathological situations. PTGF (platelet derived growth factor) and TGF-β (transforming growth factor – beta) together with the BMPs are the most important factors in the process of bone healing. The new research [1] data make the situation even more complex. Differences in the dynamic of bone healing in various parts of skeleton are well documented in literature. In population of healthy people the cortical bone heals within 4–8 months, and trabecular bone in 3–6 months. The healing of cranial bones can take from several weeks to 5 years. Broken mandible heals normally during 3–4 weeks. It takes several months for healing of broken bones of pelvis. Broken humeri are healed in 3–6 months. Similar time is needed for healing of femurs. Complexity of orthopaedic situation has important influence on time of bone repair [2-7]. BMPs play very important role in bone physiology influencing bone growth, turnover, bone formation and cartilage induction [8]. Their influence is not restricted to bone tissue. BMPs regulate apoptosis in various types of tissues [9,10]. It seems that the study of some BMPs isoforms reveals unexpected and very important activities of these proteins. In one of the recent publication by the group of Vescovi it was shown that the BMP-4 elicits strongest effect in triggering a significant reduction in tumor-initiating precursors of human glioblastoma [11]. All BMPs, except BMP-1, belong to the superfamily of transforming growth factors β, forming large group of signaling molecules [10,12-15]. Their activity is related only to dimeric form. Both homodimers as well as heterodimers are active [13,16], although their biological activity differs [14]. High activity of heterodimers BMP-4–7 and BMP-2–7 was established in vitro and in vivo [13]. High osteoinductive potency was proved for heterodimers BMP-2–6 in comparison with respective homodimers [17,18]. In bone matrix BMPs are connected with collagen and are not active unless released by the action of collagenases of osteoclasts [14]. According to the literature [19] BMPs -2, -4, -6 exert high osteoinductive potential, influencing odontogenesis [10,19-21], bone regeneration and healing [13,22-27], bone formation [15,17,28-31] and heterotopic bone induction [32-34]. In tissue culture BMPs are needed for formation of osteogenic cell lines [13,32,34,35]. The aim of this paper is to show that, in spite of incomplete knowledge of the mechanisms of bone homeostasis, some important differences exist at the molecular level, which can explain the differences in the dynamic of healing of distinct parts of human skeleton. By the use of quantitative real-time RT-PCR we were able to show the differences in the level of expression of some isoforms of BMPs in various bones or their parts. The results were confirmed by the analysis of the electrophoretic bands.

Methods

Tissue samples and total RNA isolation and quantification

Forty two biopsies of normal bone tissue taken post mortem from six cadavers of young healthy men who died in traffic accidents were frozen. Biopsies were taken from seven different bones. The cadavers are treated as "young healthy" after the routine serology done for all tissue bank donors. Biopsies (5–7 cm long and 2–3 cm wide) were taken from seven different bones. Bone marrow was removed from trabecular bone by the routine technique used in our bone bank. There were: cranial flat bones, corpus mandibulae, diaphysis radii, distal epiphysis radii, ala ossis ilii, diaphysis femoris and distal epiphysis femoris. Total RNA was extracted using TRIzol Reagent (GIBCO BRL) according to manufacturer's recommendations. Frozen in liquid nitrogen and physically powdered bone (200 mg) was suspended in 1 ml of TRIzol Reagent, vortexed and incubated 30 min at room temperature with continuous horizontal rotation. The RNA pellet was dissolved in 20–30 μl of sterile diethylpyrocarbonate-treated Mili-Q water and quantified spectrophotometrically at 260 nm. The quality of the extracted RNAs was verified by agarose gel electrophoresis. RNAs were stored as a water solution at -70°C. The "donors" were transported after accidents to the Dept. of Forensic Medicine and located for the night in cold compartments. The samples were collected in the morning after medico-legal section and frozen in dry ice. We never attempted the investigation on degradation of beta-actin or BMPs – mRNAs as a function of time.

Reverse transcription

Single stranded complementary DNA (cDNA) was synthesized with oligo(dT)12–18 primers from 5 μg of total RNA using SUPERSCRIPT First-Strand Synthesis System for RT-PCR (GIBCO BRL) accordingly to the manufacturer's instruction.

Quantitation of BMPs expression by real-time PCR

Accumulation of PCR products was measured in real-time by using QuantiTect SYBR Green PCR Kit (Qiagen). The sequences of primers are listed in Table 1. Reaction was performed in DNA Engine Opticon® 2 Real-Time Detection System (MJ Research) three times for each probe starting with 10 – 15 min of preincubation at 94°C followed by 45 amplification cycles as follows: 94°C for 1 min, annealing temperature for 1 min and 72°C for 1 min. Beta-actin was used as housekeeping gene for arbitrary unit calculation for every tested gen. Additionally product identity was confirmed by electrophoresis on a 1.7% agarose (GIBCO BRL) gel and visualized by ethidium bromide (SIGMA) staining under UV light.
Table 1

Primer sequences and sizes of amplicons generated by Real-time RT-PCR

mRNAForward primer (5'-3')Reverse primer (5'-3')Annealing [°C]Amplicon [bp]Accession numberCitation
BMP-2ATGGATTCGTGGTGGAAGTGGTGGAGTTCAGATGATCAGC58349NM_001200.2[41]
BMP-4AGCATGTCAGGATTAGCCGATGGAGATGGCACTCAGTTCA58399NM_130851.1[41]
BMP-6CAGCCTGCAGGAAGCATGAGCAAAGTAAAGAACCGAGATG53246NM_001718.2[42]
β-actinGGGTCAGAAGGATTCCTATGGGTCTCAAACATGATCTGGG58237NM_001101.2[43]
Primer sequences and sizes of amplicons generated by Real-time RT-PCR Statitistics: All statistical analysis was performed using the STATISTICA 5.0 software (StatSoft, Inc., STATISTICA for Windows, Tulsa, OK). We compared the analysed groups using the analysis of variance (ANOVA). Levels of statistical significance was set as p = 0,05: S-significant difference (p < = 0,05), NS – no statistical difference was found (p > 0,05).

Results

Real-time PCR technique was very useful for detection, determination and comparison of three BMP isoforms expressions. The use of β-actin gene expression as a housekeeping gene allowed for calculation of arbitrary units and for comparison of BMP-2, BMP-4 and BMP-6 genes expression not only between them but also between different types of bones. Obtained results showed significant expression of two isoforms of these proteins – BMP-2 and BMP-4 (Figures 1 and 2, respectively). Expression of BMP-6 was not detected. Melting temperatures of amplicons demonstrate their specifity (Figure 3) and electrophoretic analysis proved identity of these products (Figures 4 and 5). This multi-analysis allowed for conclusions that there is no BMP-6 gene expression in all examined bone samples.
Figure 1

Comparison of BMP-2 expression levels in separate bone groups. Box plot graph, Mean, SE – Standard error, SD – Standard Deviation.

Figure 2

Comparison of BMP-4 expression levels in separate bone groups. Box plot graph, Mean, SE – Standard error, SD – Standard Deviation.

Figure 3

Expression of BMPs in different bone biopsies derived from 6 patients quantified by real-time PCR.

Figure 4

Melting curves of real-time PCR products.

Figure 5

Electrophoretic analysis of real-time PCR products.

Comparison of BMP-2 expression levels in separate bone groups. Box plot graph, Mean, SE – Standard error, SD – Standard Deviation. Comparison of BMP-4 expression levels in separate bone groups. Box plot graph, Mean, SE – Standard error, SD – Standard Deviation. Expression of BMPs in different bone biopsies derived from 6 patients quantified by real-time PCR. Melting curves of real-time PCR products. Electrophoretic analysis of real-time PCR products.

Discussion

In this paper we demonstrated the differences in expression of m-RNA for isoforms BMP-2, BMP-4 in various parts of the human skeleton (Table 2).
Table 2

The number and codes of examined skeletal bone samples

Group NameGroup CodeN
BMP – 2BMP – 4

Cranial flat bonesBone 11818
Corpus mandibulaeBone 21818
Diaphysis radiiBone 31818
Distal epiphysis radiiBone 41818
Ala ossis iliiBone 51818
Diaphysis femorisBone 61818
Distal epiphysis femorisBone 71818
The number and codes of examined skeletal bone samples These differences concerned expression of m-RNAs for genes BMP-2 and BMP-4. In the same bone sample the level of expression of m-RNAs for BMP-2 and BMP-4 differ. These differences are significant when compact bone and trabecular bone are compared. Results of descriptive statistics (Fig 1) show that expression of m-RNA for BMP-2 is higher in ala ossis illi, and in trabecular bone of epiphyses of long bones as well as of flat bones then in corpus mandibulae and in the compact bone of diaphyses of long bones (Fig 1). The level of expression of BMP-4 is higher in trabecular bone in epiphyses of long bones, ala ossis illi and corpus mandibulae then in the compact bone of diaphyses of long bones and cranial flat bones (Fig 2). In all examined samples the level of expression of m-RNA for BMP-4 was higher than for BMP-2 (Fig. 1 and Fig. 2). Several repetitions of measurements by real-time RT-PCR excluded expression of mRNA for BMP-6 in analysed samples. Our results differ from the ones which were published by the Thailand group [36]. We are not fully convinced by their results. They used the semiquantitative technique of RT-PCR and the measurements were based on the intensity of fluorescence of the agarose gels standardized against cDNA for control gene for GAPDH (glyceraldehyde-3-phosphate dehydrogenase). Their samples were taken from patients in the course of surgery and it is difficult to call them "normal control samples". In the healing bones after fracture, activation of BMP-6 gene is expected. Literature data [28,37,38] allow us to assume, that the lack of m-RNA for BMP-6 in all our samples was compensated by activity of BMP-2 [28]. Because of the high osteogenic activity of homodimers BMP-2/BMP-2 and BMP-4/BMP-4 and of high probability of formation of heterodimers BMP-2/BMP-4, the lack of BMP-6 can be explained by the substitution by homodimers BMP-2/BMP-4. The additional argument for our reasoning is the high identity in sequence of proteins BMP-2 and BMP-4 reaching 92% [10,13,39,40]. Both belong to the same subclass, in contrast to BMP-6, which is the member of different subfamily.

Conclusion

The analysis of various parts of skeleton of six healthy men who died in traffic accidents showed several differences in expression of some BMPs- isoforms as measured by real-time RT-PCR spectrometry: 1. Various bones forming the skeleton differ in the level of expression of BMP-2 and BMP-4 isoforms. 2. Significant differences were found in expression of BMP-2 between cranial flat bones and ala ossis ilii, corpus mandibulae and ala ossis ilii, diaphysis radii and ala ossis ilii, diaphysis femoris and distal epiphysis femoris (Table 3, Figure 1)
Table 3

Evaluation of significant differences between mean levels of BMP-2 expression in all examined bones. S – significant difference (p < = 0,05); NS – no statistical difference was found (p > 0,05)

Bone 1Bone 2Bone 3Bone 4Bone 5Bone 6Bone 7
Bone 1-NSNSNSSNSNS
Bone 2NS-NSNSSNSNS
Bone 3NSNS-NSSNSNS
Bone 4NSNSNS-NSNSNS
Bone 5SSSNS-SNS
Bone 6NSNSNSNSS-NS
Bone 7NSNSNSNSNSNS-
Evaluation of significant differences between mean levels of BMP-2 expression in all examined bones. S – significant difference (p < = 0,05); NS – no statistical difference was found (p > 0,05) 3. Significant differences were found in expression of BMP-4 between cranial flat bones and ala ossis ilii, cranial flat bones and distal epiphysis radii, corpus mandibulae and distal epiphysis radii, diaphysis and distal epiphysis radii, diaphysis radii and ala ossis ilii, diaphysis radii and ala ossis ilii, distal epiphysis radii and ala ossis ilii, distal epiphysis radii and diaphysis femoris, ala ossis ilii and diaphysis femoris, diaphysis and distal epiphysis femoris. (Table 4, Figure 2).
Table 4

Evaluation of significant differences between mean levels of BMP-4 expression in all examined bones. S – significant difference (p < = 0,05); NS – no statistical difference was found (p > 0,05)

Bone 1Bone 2Bone 3Bone 4Bone 5Bone 6Bone 7
Bone 1-NSNSSSNSNS
Bone 2NS-NSSNSNSNS
Bone 3NSNS-SSNSNS
Bone 4SSS-SSNS
Bone 5SNSSS-SNS
Bone 6NSNSNSSS-S
Bone 7NSNSNSNSNSS-
Evaluation of significant differences between mean levels of BMP-4 expression in all examined bones. S – significant difference (p < = 0,05); NS – no statistical difference was found (p > 0,05) 4. Significant differences exist in the mean values of the levels of expression of BMP-2 when compared with the level of BMP-4 between the following parts of skeletons: diaphysis radii, distal epiphysis radii, ala ossis ilii, and distal epiphysis femoris (Table 5).
Table 5

The results of the comparison by the Analysis of Variance (ANOVA) (p = 0,05) of the mean levels of expression of BMP-2 and the levels of BMP-4 in the groups of examined bones. S – significant difference (p < = 0,05); NS – no statistical difference was found (p > 0,05)

Mean BMP-2Mean BMP-4Std. Dev. BMP-2Std. Dev. BMP-4Valid N BMP-2Valid N BMP-4Fp
Bone 1NS90,720894,31287,65049,499418181,56100,2200
Bone 2NS89,798198,208110,418714,263618184,08040,0513
Bone 3S89,629497,06686,295210,194118186,93570,0126
Bone 4S93,3007106,228110,48618,3981181816,66660,0002
Bone 5S95,6507102,55529,43789,296218184,88960,0338
Bone 6NS89,595391,84718,716910,104518180,51240,4789
Bone 7S92,2981100,28368,080812,699018185,06630,0309
The results of the comparison by the Analysis of Variance (ANOVA) (p = 0,05) of the mean levels of expression of BMP-2 and the levels of BMP-4 in the groups of examined bones. S – significant difference (p < = 0,05); NS – no statistical difference was found (p > 0,05) 5. In all other measured parts of skeleton the levels of expression of the two isoforms of BMP were similar and did not differ significantly. 6. The expression of BMP-6 isoform was not found in all examined samples. The obtained results might help to understand the differences in the speed of healing of various parts of the skeleton. We have started the measurements of samples of callus obtained in the course of surgical revisions of slow healing bone fractures. The obtained results might also have some value for the bone banks where the level of expression of BMPs could change after single steps of bone preservation as freezing, liophilisation, radiation sterilization etc. The expected role of bone implants prepared in bone banks is the promotion of bone healing by two processes – conduction and induction. The process of bone induction in human orthopaedic practice is not well documented. Some bone banks try to promote this ability by adding synthetic recombined BMPs to bone implants, sometimes with the addition of hydroxyapatite. This is why the knowledge of bioinductive properties of single parts of skeleton is important.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

All authors contributed equally to this work

Pre-publication history

The pre-publication history for this paper can be accessed here:
  39 in total

Review 1.  Discovery and development of BMPs.

Authors:  Rozalia Dimitriou; Peter V Giannoudis
Journal:  Injury       Date:  2005-11       Impact factor: 2.586

2.  Expression of bone morphogenetic proteins in normal human intramembranous and endochondral bones.

Authors:  S Suttapreyasri; S Koontongkaew; A Phongdara; U Leggat
Journal:  Int J Oral Maxillofac Surg       Date:  2006-03-02       Impact factor: 2.789

Review 3.  Bone morphogenetic protein in spinal fusion: overview and clinical update.

Authors:  B R Subach; R W Haid; G E Rodts; M G Kaiser
Journal:  Neurosurg Focus       Date:  2001-04-15       Impact factor: 4.047

Review 4.  Use of bone morphogenetic proteins in traumatology.

Authors:  R J Westerhuis; R L van Bezooijen; P Kloen
Journal:  Injury       Date:  2005-08-25       Impact factor: 2.586

5.  Temporal and spatial expression of bone morphogenetic protein-2, -4, and -7 during distraction osteogenesis in rabbits.

Authors:  F Rauch; D Lauzier; S Croteau; R Travers; F H Glorieux; R Hamdy
Journal:  Bone       Date:  2000-09       Impact factor: 4.398

6.  Inhibition of osteoblast differentiation by tumor necrosis factor-alpha.

Authors:  L Gilbert; X He; P Farmer; S Boden; M Kozlowski; J Rubin; M S Nanes
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

7.  Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

Authors:  S G M Piccirillo; B A Reynolds; N Zanetti; G Lamorte; E Binda; G Broggi; H Brem; A Olivi; F Dimeco; A L Vescovi
Journal:  Nature       Date:  2006-12-07       Impact factor: 49.962

8.  Involvement of endogenous bone morphogenetic protein (BMP) 2 and BMP6 in bone formation.

Authors:  Fumitaka Kugimiya; Hiroshi Kawaguchi; Satoru Kamekura; Hirotaka Chikuda; Shinsuke Ohba; Fumiko Yano; Naoshi Ogata; Takenobu Katagiri; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Ung-il Chung
Journal:  J Biol Chem       Date:  2005-08-18       Impact factor: 5.157

9.  Endocrine regulation of energy metabolism by the skeleton.

Authors:  Na Kyung Lee; Hideaki Sowa; Eiichi Hinoi; Mathieu Ferron; Jong Deok Ahn; Cyrille Confavreux; Romain Dacquin; Patrick J Mee; Marc D McKee; Dae Young Jung; Zhiyou Zhang; Jason K Kim; Franck Mauvais-Jarvis; Patricia Ducy; Gerard Karsenty
Journal:  Cell       Date:  2007-08-10       Impact factor: 41.582

10.  Medium- and long-term results of open reduction and internal fixation for unstable pelvic ring fractures.

Authors:  P Korovessis; A Baikousis; M Stamatakis; P Katonis
Journal:  Orthopedics       Date:  2000-11       Impact factor: 1.390

View more
  11 in total

1.  The influence of follistatin on mechanical properties of bone tissue in growing mice with overexpression of follistatin.

Authors:  Anna Gajos-Michniewicz; Elzbieta Pawlowska; Tomasz Ochedalski; Agnieszka Piastowska-Ciesielska
Journal:  J Bone Miner Metab       Date:  2012-02-07       Impact factor: 2.626

2.  The effects of low-intensity pulsed ultrasound on tendon-bone healing in a transosseous-equivalent sheep rotator cuff model.

Authors:  Vedran Lovric; Michael Ledger; Jerome Goldberg; Wade Harper; Nicky Bertollo; Matthew H Pelletier; Rema A Oliver; Yan Yu; William R Walsh
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-03-31       Impact factor: 4.342

3.  Hypoxia inhibits hepcidin expression in HuH7 hepatoma cells via decreased SMAD4 signaling.

Authors:  Timothy B Chaston; Pavle Matak; Katayoun Pourvali; Surjit K Srai; Andrew T McKie; Paul A Sharp
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

4.  Delivery of siRNA silencing Runx2 using a multifunctional polymer-lipid nanoparticle inhibits osteogenesis in a cell culture model of heterotopic ossification.

Authors:  Swati Mishra; Asa D Vaughn; David I Devore; Charles M Roth
Journal:  Integr Biol (Camb)       Date:  2012-12       Impact factor: 2.192

5.  Validation of adequate endogenous reference genes for the normalisation of qPCR gene expression data in human post mortem tissue.

Authors:  Antje Koppelkamm; Benedikt Vennemann; Tony Fracasso; Sabine Lutz-Bonengel; Ulrike Schmidt; Marielle Heinrich
Journal:  Int J Legal Med       Date:  2010-03-19       Impact factor: 2.686

6.  Levels of expression for BMP-7 and several BMP antagonists may play an integral role in a fracture nonunion: a pilot study.

Authors:  Marc Fajardo; Chuan-Ju Liu; Kenneth Egol
Journal:  Clin Orthop Relat Res       Date:  2009-07-14       Impact factor: 4.176

7.  Expression of osteogenic molecules in the caudate nucleus and gray matter and their potential relevance for Basal Ganglia calcification in hypoparathyroidism.

Authors:  Ravinder Goswami; Tabin Millo; Shruti Mishra; Madhuchhanda Das; Mansi Kapoor; Neeraj Tomar; Soma Saha; Tara Shankar Roy; Vishnubhatla Sreenivas
Journal:  J Clin Endocrinol Metab       Date:  2014-02-19       Impact factor: 5.958

Review 8.  Biology of BMP signalling and cancer.

Authors:  M Blanco Calvo; V Bolós Fernández; V Medina Villaamil; G Aparicio Gallego; S Díaz Prado; E Grande Pulido
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

9.  Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.

Authors:  A Seckinger; T Meissner; J Moreaux; H Goldschmidt; G M Fuhler; A Benner; M Hundemer; T Rème; J D Shaughnessy; B Barlogie; U Bertsch; J Hillengass; A D Ho; V Pantesco; A Jauch; J De Vos; J F Rossi; T Möhler; B Klein; D Hose
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

10.  Periarticular bone loss in antigen-induced arthritis.

Authors:  Cecilia Engdahl; Catharina Lindholm; Alexandra Stubelius; Claes Ohlsson; Hans Carlsten; Marie K Lagerquist
Journal:  Arthritis Rheum       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.